Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment

BACKGROUND: The prognostic values of preoperative tumor markers (TMs) remain elusive in patients with locally advanced gastric cancer (LAGC) after neoadjuvant chemotherapy treatment (NACT). This study aimed to assess and establish a novel scoring system incorporating carcinoembryonic antigen (CEA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zining, Wang, Yinkui, Shan, Fei, Ying, Xiangji, Zhang, Yan, Li, Shuangxi, Jia, Yongning, Miao, Rulin, Xue, Kan, Li, Zhemin, Li, Ziyu, Ji, Jiafu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272383/
https://www.ncbi.nlm.nih.gov/pubmed/34246249
http://dx.doi.org/10.1186/s12876-021-01785-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272383/
https://www.ncbi.nlm.nih.gov/pubmed/34246249
http://dx.doi.org/10.1186/s12876-021-01785-7

Ejemplares similares